FDG-PET scan
Sponsors
Radboud University Medical Center, European Organisation for Research and Treatment of Cancer - EORTC, Washington University School of Medicine, University of Oklahoma, University of Utah
Conditions
Adrenal TumorsAlzheimer's DiseaseAtopic DermatitisColorectal CancerColorectal Liver MetastasesCoronary AtherosclerosisLymphomaNeoplasm Metastasis
Early Phase 1
Phase 3
Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases
CompletedNCT00119899
Start: 2002-03-31End: 2005-06-30Target: 150Updated: 2005-08-31
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
NCT00433433
Start: 2006-10-31Updated: 2021-02-03
Unknown Phase
Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules
CompletedNCT00537797
Start: 2004-08-31End: 2014-02-28Updated: 2014-09-22
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
TerminatedNCT00775957
Start: 2008-10-31Target: 35Updated: 2010-09-28
Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study
CompletedNCT01284829
Start: 2011-02-04End: 2023-04-05Updated: 2023-04-06
Trial on Vascular Inflammation in Atopic Dermatitis
CompletedNCT02926807
Start: 2017-01-31End: 2018-11-30Updated: 2018-12-19
The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)
RecruitingNCT06440122
Start: 2024-05-31End: 2024-12-31Target: 100Updated: 2024-06-03